Sagimet Biosciences grants 260,700 inducement stock options to new hiresPUBT·Aug 17 at 03:28 PMSGMT+0.69%
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | SGMT Stock NewsStockTitan·Aug 17 at 07:28 AMSGMT+0.69%
Sagimet Biosciences Eyes U.S. Phase III Acne Study After Positive China DataMarket Beat·Aug 17 at 03:01 AMSGMT+0.69%01672-2.24%
Sagimet Biosciences shares are trading higher after Citizens raised its price target on the stock from $12 to $29.benzinga_article·Aug 14 at 01:11 PMSGMT+0.69%
Sagimet director George Kemble disposes of 20,206 common shares worth $201,160.97PUBT·Aug 12 at 06:41 PMSGMT+0.69%
Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate UpdatesUnusual Whales·Aug 11 at 06:32 AMSGMT+0.69%
Renaissance Technologies LLC Increases Stake in Sagimet Biosciences Inc. $SGMTMarket Beat·Aug 9 at 03:40 AMSGMT+0.69%
Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Moderate Buy" by BrokeragesMarket Beat·Aug 6 at 03:44 AMSGMT+0.69%
